https://www.selleckchem.com/pr....oducts/CP-690550.htm
ts treated with peritoneal dialysis. (Funded by the Swiss National Science Foundation and others.). The prognoses with respect to mortality and hepatic and nonhepatic outcomes across the histologic spectrum of nonalcoholic fatty liver disease (NAFLD) are not well defined. We prospectively followed a multicenter patient population that included the full histologic spectrum of NAFLD. The incidences of death and other outcomes were compared across baseline histologic characteristics. A total of 1773 adults with NAFLD were followed for a
Beğen
Yorum Yap
Paylaş
